SSRI's are used in the management of depression. They ease the symptoms by raising the levels of serotonin in the brain. Serotonin is one of the neuro transmitters or chemical messengers which manages impulses (Popovic et al., 2015). SSRI's reduce the re uptake of serotonin thus making it more available in the system. Serotonin improves or regularises sleep patterns and normalizes moods while stabilising emotional reactions. They are also popular because they activate or improve the performance of other drugs such as those that treat anxiety (Popovic et al., 2015). The drugs also have fewer side effects than most of the other therapies and they do not often lead to addiction or dependency. Some patients with a long history of mental health problems benefit more if they are not affected by the few side effects they may cause.
Adults and teenagers display the same symptoms as indicators of depression. However, they go through slightly different kinds of treatment because the brain has developed differently. The part of the teenage brain with gray matter is still in the developing stages. The frontal cortex of the teen brain is also still developing(Mojtabai et al., 2016). This is the reason why drug treatment for teenagers is discouraged unlees the case is severe. Cognitive behaviour therapy is the moat popular option as it does not interfere with the development of the brain. Adults are more receptive to drug options because their brain development is complete.
Delegate your assignment to our experts and they will do the rest.
Comorbid psychiatric disorders may need the intervention of the drug therapy to help with the drug addiction before the other issues are adressed. This will help prevent a new drug addiction and set the necessary foundation for the talk therapy (Mojtabai et al., 2016). Patients who are taking multiple antipsychotic medication can be advised to take note of the success or failure of the combination therapy. The patients should also take note of the side effects of the treatment so as not to develop treatment related anxiety from the new reactions.
References
Popovic, D., Vieta, E., Fornaro, M., & Perugi, G. (2015). Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants. Journal of affective disorders, 173 , 211-215.
Mojtabai, R., Olfson, M., & Han, B. (2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics , e20161878.
